Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA29	TRIJAN	G	Tofacitinib - 10mg	10mg	Tablet, film coated	84,793,962 L.L
M01AH01	JOSWE FLAMEX 400	G	Celecoxib - 400mg	400mg	Capsule	1,659,645 L.L
N02BE01	SICADOL	G	Paracetamol - 1000mg	1000mg	Tablet	423,310 L.L
N05AB02	FLUPHENAZINE HCl	G	Fluphenazine (HCl) - 5mg	5mg	Tablet, scored	624,567 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 37.5mg	37.5mg	Capsule, prolonged release	538,881 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	952,208 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 10g/100ml	10g/100ml	Injectable solution	194,211 L.L
C09CA01	LOSARTAN-REMEDICA	G	Losartan potassium - 50mg	50mg	Tablet, film coated	642,357 L.L
C10AA05	TARDEN	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, film coated	880,537 L.L
D07XB05	ECOZONE	G	Dexamethazone sodium phosphate - 0.1%, Econazole nitrate - 1%		Cream	364,757 L.L
G04BE08	VIVIDA 20	G	Tadalafil - 20mg	20mg	Tablet, film coated	1,721,398 L.L
J01MA12	LEVOFLOX-MEDIS 500	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	1,834,345 L.L
N05AB03	PERPHENAZINE	G	Perphenazine - 8mg	8mg	Tablet, scored	624,567 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	383,955 L.L
R03AL02	DUOLIN RESPULES	G	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide (monohydrate) - 500mcg/2.5ml		Inhaltion solution with nebuliser	417,935 L.L
S01AE07	FORTYMOX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops solution	772,709 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	2,015,764 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 10g/100ml	10g/100ml	Injectable solution	219,493 L.L
C10AA05	TORVACOL 20	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, coated	1,128,828 L.L
G04BE08	VIVIDA 20	G	Tadalafil - 20mg	20mg	Tablet, film coated	624,567 L.L
J01MA12	LOXAMOX	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	747,176 L.L
M01AH05	ARTRIX 60	G	Etoricoxib - 60mg	60mg	Tablet, film coated	1,054,596 L.L
N02BE01	SULDEX B	G	Paracetamol - 150mg	150mg	Suppository	117,746 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	575,933 L.L
R03AL02	IPRASAL VEM	G	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide (monohydrate) - 0.5mg/2.5ml		Inhaltion solution with nebuliser	417,935 L.L
S01AE07	IMOX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	464,970 L.L
A06AB02	SUPPOLAX	G	Bisacodyl - 10mg	10mg	Suppository	575,270 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L